COCHW Envoy Medical, Inc. - Warrant
NASDAQ · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$0.04
· % 处于52周区间
· 高于低点
· 至高点
$0.0352周低点
$0.0752周高点
P/E (TTM)
-0.1
EPS (TTM)
$-0.77
收入 (TTM)
$207.0K
COCHW 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.04
P/E (TTM)
-0.1
EPS (TTM)
$-0.77
收入 (TTM)
$207.0K
ROE (TTM)
176.2%
52周区间
$0–$0
COCHW 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$241.0K2022-12-31 → 2025-12-31
EPS$-1.232022-12-31 → 2025-12-31
自由现金流·2023-12-31 → 2024-12-31
净利率-11304.8%2023-12-31 → 2024-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | COCHW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -0.1 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | COCHW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -11411.1% | · | · | · | |
| 净利润率 (TTM) | -11304.8% | · | · | · | |
| ROA (TTM) | -138.3%5年均值 ≈-198.1% | ≈-198.1% | · | · | |
| ROE (TTM) | 176.2%5年均值 ≈-488.6% | ≈-488.6% | · | · |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | COCHW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.75年均值 ≈0.7 | ≈0.7 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | COCHW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 7.1%5年均值 ≈3.9% | ≈3.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 0.56% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | COCHW | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$5.6K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $241.0K | $225.0K | $316.0K | $237.0K | |
| Cost of Revenue | $874.0K | $742.0K | $789.0K | $498.0K | |
| R&D Expense | $12M | $10M | $9M | $5M | |
| SG&A Expense | $8M | $7M | $7M | $3M | |
| Operating Expenses | $23M | $19M | $19M | $9M | |
| Operating Income | $-22M | $-19M | $-18M | $-9M | |
| Interest Income | · | · | · | $6M | |
| Other Non-op | $-23.0K | $-26.0K | $54.0K | $-127.0K | |
| Pretax Income | $-24M | $-21M | · | $21M | |
| Net Income | $-24M | $-21M | $-30M | $-16M | |
| EPS (Basic) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | |
| EPS (Diluted) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | |
| Shares (Basic) | 23,259,598 | 18,790,448 | 12,295,391 | 10,123,169 | |
| Shares (Diluted) | 23,259,598 | 18,790,448 | 12,295,391 | 10,123,169 | |
| EBITDA | · | $-19M | $-18M | $-5M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $4M | $183.0K | |
| Receivables | $34.0K | $38.0K | $70.0K | $41.0K | |
| Inventory | $2M | $2M | $1M | $1M | |
| Prepaid Expense | $941.0K | $887.0K | $2M | $129.0K | |
| Current Assets | $6M | $9M | $7M | $2M | |
| PP&E (Net) | $1M | $1M | $351.0K | $331.0K | |
| PP&E (Gross) | $6M | $6M | $5M | · | |
| Accum. Depreciation | $5M | $5M | $5M | · | |
| Total Assets | $9M | $12M | $8M | $3M | |
| Accounts Payable | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | $8M | $4M | $5M | $608.0K | |
| Current Liabilities | $12M | $8M | $7M | $3M | |
| Other Non-current Liabilities | $27.0K | $891.0K | · | $127.0K | |
| Total Liabilities | $20M | $30M | $10M | $39M | |
| Common Stock | $3.0K | $2.0K | · | · | |
| Paid-in Capital | $301M | $266M | $256M | $190M | |
| Retained Earnings | $-313M | $-285M | $-257M | $-226M | |
| AOCI | $-120.0K | $-123.0K | $-118.0K | $-115.0K | |
| Stockholders' Equity | $-12M | $-19M | $-2M | $-36M | |
| Liabilities + Equity | $9M | $12M | $8M | $3M | |
| Shares Outstanding | · | 21,326,609 | 18,599,982 | · |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $657.0K | $562.0K | $2M | · | |
| Deferred Tax | · | $3M | $6M | $645.0K | |
| Operating Cash Flow | $-18M | $-18M | $-17M | $-9M | |
| CapEx | $179.0K | $980.0K | $153.0K | $218.0K | |
| Investing Cash Flow | $-179.0K | $-980.0K | $-153.0K | $-218.0K | |
| Stock Issued | $414.0K | · | $109.0K | · | |
| Dividends Paid | $2M | $2M | · | · | |
| Financing Cash Flow | $17M | $20M | $21M | $8M | |
| Net Change in Cash | $-2M | $1M | $4M | $-938.0K | |
| Free Cash Flow | · | $-19M | $-18M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | -8558.2% | -5813.6% | · | |
| Net Margin | · | -9242.2% | -9464.6% | · | |
| EBITDA Margin | · | -8558.2% | -5813.6% | · | |
| ROA | · | -210.0% | -586.7% | 4.5% | |
| ROE | · | 111.2% | -1978.0% | -88.5% | |
| ROIC | · | · | · | 25.3% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 1.2 | 1.0 | 0.0 | |
| Quick Ratio | · | 0.7 | 0.6 | 0.0 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.1 | · | |
| Inventory Turnover | · | 0.5 | 0.6 | · | |
| Receivables Turnover | · | 4.2 | 5.7 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | · | · | $-0.09 | · | |
| Revenue / Share | · | $0.01 | $0.03 | · | |
| Cash Flow / Share | · | $-0.96 | $-1.41 | · | |
| Cash / Share | · | · | $0.22 | · | |
| EPS (TTM) | $-1.23 | $-1.49 | $-2.54 | $-1.57 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 7.1% | -28.8% | 33.3% | · | |
| Revenue CAGR 3Y | 0.56% | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $241.0K | $225.0K | $316.0K | $237.0K | |
| Net Income TTM | $-24M | $-21M | $-30M | $-16M | |
| Payout Ratio | · | -11.8% | · | · | |
| Annual Payout | $2M | $2M | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51.0K | $39.0K | $75.0K | $42.0K | $78.0K | $46.0K | $42.0K | $56.0K | $68.0K | $59.0K | $95.0K | $80.0K | $63.0K | $78.0K | $20.0K | $57.0K | |
| Cost of Revenue | $278.0K | $313.0K | $211.0K | $203.0K | $234.0K | $226.0K | $157.0K | $187.0K | $245.0K | $153.0K | $263.0K | $189.0K | $162.0K | $175.0K | $151.0K | $106.0K | |
| R&D Expense | $3M | $4M | $5M | $3M | $2M | $3M | $2M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $1M | $935.0K | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $3M | $1M | $2M | $1M | $447.0K | $812.0K | |
| Operating Expenses | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $7M | $3M | $5M | $4M | $3M | $2M | |
| Operating Income | $-6M | $-6M | $-6M | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-7M | $-3M | $-4M | $-4M | $-5M | $-2M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | $528.3K | $3M | · | $2M | |
| Other Non-op | $166.0K | $6.0K | $-16.0K | $5.0K | $-1.0K | $-11.0K | $-17.0K | $13.0K | $-8.0K | $-14.0K | $113.0K | $46.0K | · | $-9M | $-8.0K | $-117.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | $-1M | $2M | · | $6M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | $121.2K | $841.5K | · | $534.0K | |
| Net Income | $-6M | $-4M | $-7M | $-6M | $-6M | $-5M | $-5M | $-6M | $-4M | $-6M | $-5M | $2M | $-13M | $-13M | $-11M | $-1M | |
| EPS (Basic) | $-0.07 | $-0.08 | $-0.27 | $-0.35 | $-0.32 | $-0.29 | $-0.40 | $-0.39 | $-0.29 | $-0.41 | $-0.05 | $0.13 | $-1.31 | $-1.31 | $-1.13 | $-0.13 | |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.27 | $-0.35 | $-0.32 | $-0.29 | $-0.40 | $-0.39 | $-0.29 | $-0.41 | $-0.05 | $0.13 | $-1.31 | $-1.31 | $-1.13 | $-0.13 | |
| Shares (Basic) | 104,039,109 | 68,934,960 | · | 21,851,606 | 21,383,852 | 21,326,609 | · | 18,616,362 | 18,599,982 | 18,599,982 | · | 10,214,183 | 10,122,581 | 10,122,581 | · | 10,123,187 | |
| Shares (Diluted) | 104,039,109 | 68,934,960 | · | 21,851,606 | 21,383,852 | 21,326,609 | · | 18,616,362 | 18,599,982 | 18,599,982 | · | 11,215,068 | 10,122,581 | 10,122,581 | · | 10,123,187 | |
| EBITDA | $-6M | $-6M | · | $-6M | $-5M | $-5M | · | $-5M | $-5M | $-5M | · | $-3M | $-98.6K | $-2M | · | $-1M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $25M | $4M | $4M | $5M | $5M | · | $4M | $2M | $5M | $4M | $7M | $132.8K | $104.0K | $183.0K | $302.0K | |
| Receivables | $49.0K | $31.0K | $34.0K | $35.0K | $43.0K | $42.0K | $38.0K | $197.0K | $174.0K | $189.0K | $70.0K | $109.0K | · | · | $41.0K | · | |
| Inventory | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | · | · | $1M | · | |
| Prepaid Expense | $593.0K | $893.0K | $941.0K | $508.0K | $576.0K | $1M | $887.0K | $842.0K | $1M | $1M | $2M | $997.0K | $264.9K | $412.9K | $129.0K | $288.2K | |
| Current Assets | $22M | $28M | $6M | $6M | $8M | $8M | $9M | $7M | $5M | $8M | $7M | $20M | $397.7K | $516.9K | $2M | $590.2K | |
| PP&E (Net) | $921.0K | $962.0K | $1M | $1M | $1M | $1M | $1M | $1M | $632.0K | $317.0K | $351.0K | $378.0K | · | · | $331.0K | · | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $6M | $6M | $6M | · | · | · | $5M | · | · | · | · | · | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | · | · | $5M | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $10M | · | · | · | · | |
| Total Assets | $24M | $30M | $9M | $8M | $10M | $10M | $12M | $9M | $7M | $8M | $8M | $21M | $45M | $46M | $3M | $428M | |
| Accounts Payable | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $913.0K | $2M | $3M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $10M | $10M | $8M | $6M | $5M | $5M | $4M | $7M | $6M | $6M | $5M | $4M | $5M | $6M | $608.0K | $3M | |
| Current Liabilities | $13M | $12M | $12M | $9M | $8M | $8M | $8M | $9M | $8M | $7M | $7M | $13M | $9M | $9M | $3M | $6M | |
| Other Non-current Liabilities | $27.0K | $27.0K | $27.0K | $891.0K | $891.0K | $891.0K | $891.0K | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $20M | $19M | $20M | $16M | $40M | $35M | $30M | $28M | $19M | $16M | $10M | $16M | $21M | $21M | $39M | $18M | |
| Common Stock | $8.0K | $8.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | $330M | $329M | $301M | $298M | $268M | $267M | $266M | $259M | $258M | $258M | $256M | $256M | · | · | $190M | · | |
| Retained Earnings | $-326M | $-319M | $-313M | $-306M | $-298M | $-291M | $-285M | $-278M | $-270M | $-265M | $-257M | $-251M | $-21M | $-19M | $-226M | $-17M | |
| AOCI | $-122.0K | $-121.0K | $-120.0K | $-120.0K | $-119.0K | $-117.0K | $-123.0K | $-121.0K | $-120.0K | $-119.0K | $-118.0K | $-116.0K | · | · | $-115.0K | · | |
| Stockholders' Equity | $3M | $10M | $-12M | $-8M | $-30M | $-24M | $-19M | $-19M | $-12M | $-7M | $-2M | $5M | $-21M | $-19M | $-36M | $-17M | |
| Liabilities + Equity | $24M | $30M | $9M | $8M | $10M | $10M | $12M | $9M | $7M | $8M | $8M | $21M | $45M | $46M | $3M | $428M | |
| Shares Outstanding | · | · | · | · | 21,520,932 | 21,326,609 | · | · | · | · | · | 19,549,982 | · | · | · | · |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $214.0K | $239.0K | $179.0K | $172.0K | $146.0K | $160.0K | $153.0K | $144.0K | $142.0K | $123.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-6M | $-6M | $-4M | $-4M | $-4M | $-5M | $-2M | $-4M | $-6M | $-11M | $-3M | $-5M | $-3M | $-2M | $-5M | |
| CapEx | · | · | $172.0K | $0 | $1.0K | $6.0K | $-534.0K | $1M | · | · | $21.0K | $62.0K | $11.0K | $59.0K | $41.0K | · | |
| Investing Cash Flow | · | · | $-172.0K | $0 | $-1.0K | $-6.0K | $534.0K | $-615.0K | $-790.0K | $-109.0K | $-21.0K | $-389M | $-389M | $-59.0K | $-41.0K | · | |
| Stock Issued | $0 | $30M | $0 | $210.0K | · | · | · | $0 | $0 | $2M | · | · | · | · | · | · | |
| Net Stock Activity | · | $30M | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Dividends Paid | · | · | $-1.0K | $0 | $607.0K | $1M | $614.0K | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-109.0K | $28M | $6M | $3M | $4M | $4M | $6M | $5M | $2M | $6M | $-1M | $409M | $394M | $4M | $2M | $5M | |
| Net Change in Cash | $-6M | $22M | $183.0K | $-2M | $-25.0K | $-171.0K | $1M | $3M | $-3M | $727.0K | $-13M | $17M | $-111.2K | $931.0K | $-426.0K | $-839.1K | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | $318.5K | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10919.6% | -15279.5% | · | -13590.5% | -6500.0% | -11102.2% | · | -8882.1% | -7147.1% | -8301.7% | · | -4231.2% | · | · | · | · | |
| Net Margin | -11729.4% | -11156.4% | · | -15433.3% | -7294.9% | -10865.2% | · | -10642.9% | -5804.4% | -10627.1% | · | 1953.8% | · | · | · | · | |
| EBITDA Margin | -10919.6% | -15279.5% | · | -13590.5% | -6500.0% | -11102.2% | · | -8882.1% | -7147.1% | -8301.7% | · | -4231.2% | · | · | · | · | |
| ROA | -35.4% | -21.6% | · | -73.8% | -68.4% | -53.0% | · | -38.9% | -15.2% | -23.1% | · | 0.70% | -0.48% | 0.30% | · | 1.3% | |
| ROE | 45.1% | 61.9% | · | 49.5% | 26.9% | 31.6% | · | 86.7% | 23.8% | 47.1% | · | -24.9% | 5.4% | -3.3% | · | -22.7% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | 0.53% | 6.0% | · | 5.4% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.3 | · | 0.6 | 0.9 | 1.1 | · | 0.8 | 0.6 | 1.1 | · | 1.6 | 0.0 | 0.1 | · | 0.1 | |
| Quick Ratio | 1.6 | 2.1 | · | 0.4 | 0.7 | 0.7 | · | 0.5 | 0.2 | 0.7 | · | 0.6 | 0.0 | 0.0 | · | 0.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.3 | 0.2 | · | 0.3 | · | · | · | · | |
| Receivables Turnover | 1.1 | 1.1 | · | 0.4 | 0.7 | 0.4 | · | 0.4 | 0.8 | 0.6 | · | 1.5 | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $-1.39 | $-1.14 | · | · | · | · | · | $0.24 | · | · | · | · | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | · | · | · | · | |
| Cash Flow / Share | · | $-0.09 | · | · | · | $-0.17 | · | · | · | $-0.30 | · | · | · | · | · | · | |
| Cash / Share | · | · | · | · | $0.25 | $0.25 | · | · | · | · | · | $0.38 | · | · | · | · | |
| EPS (TTM) | $-0.77 | $-1.02 | · | $-1.36 | $-1.40 | $-1.37 | · | $-1.14 | $-0.62 | $-1.64 | · | $-3.62 | $-3.88 | · | · | · |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $207.0K | $234.0K | · | $208.0K | $222.0K | $212.0K | · | $278.0K | $302.0K | $297.0K | · | $241.0K | $218.0K | · | · | · | |
| Net Income TTM | $-23M | $-23M | · | $-22M | $-21M | $-20M | · | $-21M | $-14M | $-23M | · | $-37M | $-39M | $-27M | · | $-9M | |
| P/E | -0.1 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1621.0% | -2147.4% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | -24.3% | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $2M | $2M | · | $2M | · | · | · | · | · | · | · | · | · | · | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $241.0K | $225.0K | $316.0K | $237.0K | · |
| 营业利润率 % | · | -8558.2% | -5813.6% | · | · |
| 净收入 | $-24M | $-21M | $-30M | $-16M | $-251.6K |
| 稀释后每股收益 (EPS) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | · | 1.2 | 1.0 | 0.0 | 0.3 |
| 速动比率 | · | 0.7 | 0.6 | 0.0 | 0.1 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | · | $-19M | $-18M | · | · |
机构持有人 (13F) 37 家申报者 · $362K 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
37
持有价值
$362K
新仓位
0
已退出持仓
1
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 0 (-2 与上一季度对比) | 1 (-1 与上一季度对比) | 1 (0 与上一季度对比) | 2 (-3 与上一季度对比) | +127K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Glen A. Taylor ×2 申报 | 2026年2月17日 | 84.80% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 2 位内幕人士 · 2 位高管 · 1 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Brent T. Lucas | Chief Executive Officer | 2026年6月19日 A | · | 0 | 0 | $0 |
| Robert Potashnick | CAO & VP of Finance | 2026年8月24日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报